Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2003 1
2006 4
2008 7
2010 2
2012 3
2013 3
2014 5
2015 13
2016 12
2017 8
2018 3
2019 8
2020 9
2021 14
2022 17
2023 29
2024 23
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote I, Pérez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martínez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Høgdall E, Fariñas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Vergote I, et al. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. J Clin Oncol. 2023. PMID: 37669480 Clinical Trial.
Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cao A, Cartmel B, Li FY, Gottlieb LT, Harrigan M, Ligibel JA, Gogoi R, Schwartz PE, Esserman DA, Irwin ML, Ferrucci LM. Cao A, et al. Among authors: gogoi r. JAMA Netw Open. 2023 Aug 1;6(8):e2326463. doi: 10.1001/jamanetworkopen.2023.26463. JAMA Netw Open. 2023. PMID: 37526937 Free PMC article. Clinical Trial.
Ocular dirofilariasis.
Nath R, Gogoi R, Bordoloi N, Gogoi T. Nath R, et al. Among authors: gogoi r. Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):157-9. doi: 10.4103/0377-4929.59213. Indian J Pathol Microbiol. 2010. PMID: 20090252 Review.
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial.
Valabrega G, Powell MA, Hietanen S, Miller EM, Novak Z, Holloway R, Denschlag D, Myers T, Thijs AM, Pennington KP, Gilbert L, Fleming E, Zub O, Landrum LM, Ataseven B, Gogoi R, Podzielinski I, Cloven N, Monk BJ, Sharma S, Herzog TJ, Stuckey A, Pothuri B, Secord AA, Chase D, Vincent V, Meyers O, Garside J, Mirza MR, Black D. Valabrega G, et al. Among authors: gogoi r. Int J Gynecol Cancer. 2025 Jun;35(6):101852. doi: 10.1136/ijgc-2024-005484. Epub 2025 Apr 19. Int J Gynecol Cancer. 2025. PMID: 39322611 Free article. Clinical Trial.
The colonial legacy of herbaria.
Park DS, Feng X, Akiyama S, Ardiyani M, Avendaño N, Barina Z, Bärtschi B, Belgrano M, Betancur J, Bijmoer R, Bogaerts A, Cano A, Danihelka J, Garg A, Giblin DE, Gogoi R, Guggisberg A, Hyvärinen M, James SA, Sebola RJ, Katagiri T, Kennedy JA, Komil TS, Lee B, Lee SML, Magri D, Marcucci R, Masinde S, Melnikov D, Mráz P, Mulenko W, Musili P, Mwachala G, Nelson BE, Niezgoda C, Novoa Sepúlveda C, Orli S, Paton A, Payette S, Perkins KD, Ponce MJ, Rainer H, Rasingam L, Rustiami H, Shiyan NM, Bjorå CS, Solomon J, Stauffer F, Sumadijaya A, Thiébaut M, Thiers BM, Tsubota H, Vaughan A, Virtanen R, Whitfeld TJS, Zhang D, Zuloaga FO, Davis CC. Park DS, et al. Among authors: gogoi r. Nat Hum Behav. 2023 Jul;7(7):1059-1068. doi: 10.1038/s41562-023-01616-7. Epub 2023 Jun 12. Nat Hum Behav. 2023. PMID: 37308536
Crouzon syndrome and the eye: An overview.
Bhattacharjee K, Rehman O, Venkatraman V, Kikkawa D, Bhattacharjee H, Gogoi R, Grewal AM, Bhattacharjee P. Bhattacharjee K, et al. Among authors: gogoi r. Indian J Ophthalmol. 2022 Jul;70(7):2346-2354. doi: 10.4103/ijo.IJO_3207_21. Indian J Ophthalmol. 2022. PMID: 35791116 Free PMC article. Review.
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer.
Chehade H, Gogoi R, Adzibolosu NK, Galoforo S, Fehmi RA, Kheil M, Fox A, Kim S, Rattan R, Hou Z, Morris RT, Matherly LH, Mor G, Alvero AB. Chehade H, et al. Among authors: gogoi r. Cancer Res Commun. 2024 Aug 1;4(8):2075-2088. doi: 10.1158/2767-9764.CRC-24-0111. Cancer Res Commun. 2024. PMID: 39028933 Free PMC article.
Adipose microenvironment promotes hypersialylation of ovarian cancer cells.
Fox A, Leonard GD, Adzibolosu N, Wong T, Tedja R, Sharma S, Gogoi R, Morris R, Mor G, Fehl C, Alvero AB. Fox A, et al. Among authors: gogoi r. Front Oncol. 2024 Jul 22;14:1432333. doi: 10.3389/fonc.2024.1432333. eCollection 2024. Front Oncol. 2024. PMID: 39104719 Free PMC article.
161 results